Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jun;50(6):1203-8.
doi: 10.1194/jlr.M800666-JLR200. Epub 2009 Jan 22.

Fatty acid 2-hydroxylase regulates cAMP-induced cell cycle exit in D6P2T schwannoma cells

Nathan L Alderson  1 , Hiroko Hama
Affiliations

Fatty acid 2-hydroxylase regulates cAMP-induced cell cycle exit in D6P2T schwannoma cells

Nathan L Alderson et al. J Lipid Res. 2009 Jun.

Abstract

Sphingolipids are ubiquitous components of eukaryotic cells that regulate various cellular functions. In many cell types, a fraction of sphingolipids contain 2-hydroxy fatty acids, produced by fatty acid 2-hydroxylase (FA2H), as the N-acyl chain of ceramide [hydroxyl fatty acid (hFA)-sphingolipids]. FA2H is highly expressed in myelin-forming cells of the nervous system and in epidermal keratinocytes. While hFA-sphingolipids are thought to enhance the physical stability of specialized membranes produced by these cells, physiological significance of hFA-sphingolipids in many other cell types is unknown. In this study, we report novel roles for FA2H and hFA-sphingolipids in the regulation of the cell cycle. Treatment of D6P2T Schwannoma cells with dibutyryl-cAMP (db-cAMP) induced exit from the cell cycle with concomitant upregulation of FA2H. Partial silencing of FA2H in D6P2T cells resulted in 60-70% reduction of hFA-dihydroceramide and hFA-ceramide, with no effect on nonhydroxy dihydroceramide and ceramide. Under these conditions, db-cAMP no longer induced cell cycle exit, and cells continued to grow and divide. Immunoblot analyses revealed that FA2H silencing prevented db-cAMP-induced upregulation of cyclin-dependent kinase inhibitors p21 and p27. These results provide evidence that FA2H is a negative regulator of the cell cycle and facilitates db-cAMP-induced cell cycle exit in D6P2T cells.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Proposed biosynthetic pathway for hFA-sphingolipids. The de novo pathway is postulated based on our in vitro and in vivo evidence (20, 22). Salvage pathways (not shown) leading to formation of hFA-sphingolipids have not been studied. In addition to C16 fatty acid, many other fatty acids (C14–C34) can be used. The N-acylation step is catalyzed by any of the six isoforms of ceramide synthase (38). GSL, glycosphingolipid; SM, sphingomyelin.
Fig. 2.
Fig. 2.
Effects of FA2H shRNA on DHC and ceramide. D6P2T cells were transfected with control shRNA (black bars) or FA2H shRNA (white bars) plasmid. Transfected cells were selected for puromycin resistance for 2 weeks. Lipids were quantified by LC/MS/MS and normalized against protein contents. The mean and SD of triplicate measurements are shown. (See supplementary Table I for the quantities of individual molecular species.) A: The sum of 13 nonhydroxy DHC and 10 hFA-DHC molecular species. B: The sum of 13 nonhydroxy ceramide and 12 hFA-ceramide molecular species.
Fig. 3.
Fig. 3.
FA2H silencing nullifies db-cAMP-induced upregulation of FA2H. D6P2T cells were transfected with control shRNA or FA2H shRNA plasmid as indicated. Transfected cells were selected for puromycin resistance for 2 weeks and then treated with vehicle only or 1 mM db-cAMP for 48 h. A: FA2H mRNA levels. FA2H mRNA levels were determined by quantitative PCR and normalized against 18s rRNA levels. The mean and SD of triplicate measurements are shown. B: FA2H activity. Crude cell lysates (50 μg protein) were used for FA2H assays. The mean and SD of triplicate measurements are shown.
Fig. 4.
Fig. 4.
FA2H silencing facilitates cell growth and inhibits db-cAMP-induced growth arrest in D6P2T cells. D6P2T cells were transfected with control shRNA or FA2H shRNA plasmid and selected for puromycin resistance for 2 weeks. A–D: Cells were treated with sham (A, C) or 0.1 mM db-cAMP (B, D) for 24 h before stained with calcein-AM. E: Cell counts in samples A–D. The counts were normalized against the cell number in A. The mean and SD of triplicate counts are shown. F: [3H]thymidine incorporation. Low confluency cells were exposed to [3H]thymidine for 5 h in a serum-free medium. After extensive washing, cells were lysed to quantify radioactivity by liquid scintillation counting. The mean and SD of sextuplicate measurements are shown.
Fig. 5.
Fig. 5.
FA2H silencing prevents upregulation of CDK inhibitors induced by db-cAMP. D6P2T cells were transfected with control shRNA or FA2H shRNA plasmid. Transfected cells were selected for puromycin resistance for 2 weeks. Cells were treated with sham, 0.1 mM, or 1 mM db-cAMP for 48 h and processed for SDS-PAGE (10 μg protein/lane).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Hakomori S. 2003. Structure, organization, and function of glycosphingolipids in membrane. Curr. Opin. Hematol. 10 16–24. - PubMed
    1. Sillence D. J., and F. M. Platt. 2004. Glycosphingolipids in endocytic membrane transport. Semin. Cell Dev. Biol. 15 409–416. - PubMed
    1. Futerman A. H., and Y. A. Hannun. 2004. The complex life of simple sphingolipids. EMBO Rep. 5 777–782. - PMC - PubMed
    1. Norton, W. T., and W. Cammer. 1984. Isolation and characterization of myelin. In Myelin. P. Morell, editor. Plenum, New York, NY. 147–195.
    1. Downing D. T. 1992. Lipid and protein structures in the permeability barrier of mammalian epidermis. J. Lipid Res. 33 301–313. - PubMed

Publication types

LinkOut - more resources